UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for HIV/AIDS, tuberculosis and malaria medicines and diagnostics for the world's poor, according to Results Beyond Investment , its 2012 Annual Report just released.
http://greatreporter.com/content/unitaid-report-cites-price-reductions-80-hivaids-tuberculosis-and-malaria-products
http://greatreporter.com/content/unitaid-report-cites-price-reductions-80-hivaids-tuberculosis-and-malaria-products
